Galapagos to enter cell therapy space with acquisition of CellPoint and AboundBio

Mechelen, Belgium-based biotech Galapagos (NASDAQ:GLPG) (OTC:GLPGF) has agreed to acquire CellPoint, a privately held developer of point-of-care CAR-T therapies and AboundBio, a company with a fully human antibody-based library.